Application of PK/PD modeling and simulation in drug discovery and development in China Blog Application of PK/PD modeling and simulation in drug discovery and development in China By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…Certara2020 年 8 月 7 日
Conventional & mechanistic IVIVC: Complementary or clashing methods? 博客 Conventional & mechanistic IVIVC: Complementary or clashing methods? An IVIVC (in vitro-in vivo correlation) is a mathematical relationship that predicts key pharmacokinetic parameters…Certara2016 年 2 月 9 日
Common misconceptions about computer system validation Blog 关于计算机系统验证的常见误解 2015 年 1 月 28 日 Drug development professionals frequently use computer systems to help them understand the…Certara2015 年 1 月 28 日
Using modeling and simulation to quantify the PK of an anti-HIV drug for babies Blog Using modeling and simulation to quantify the PK of an anti-HIV drug for babies As a scientist at Certara and proud Dad to my three kids, pediatric drug development…Certara2015 年 1 月 15 日
Calculating urine PK parameters BlogKnowledge Base Calculating urine PK parameters Pharmacokinetic analysis normally focuses on systemic exposure to a drug; however, much can be learned…Certara2012 年 12 月 6 日
The difference between Vd and Vss BlogKnowledge Base The difference between Vd and Vss There are many terms used to represent volume of distribution, but two common ones are…Certara2011 年 3 月 31 日
Understanding volume of distribution BlogKnowledge Base Understanding volume of distribution Watch our on demand webinar to discover fast, flexible, frictionless PK/PD workflows with Phoenix Cloud.…Certara2010 年 6 月 5 日